These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32197031)

  • 1. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
    Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
    Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
    Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C
    PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of microRNA-133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway.
    Zhang P; Chen FZ; Jia QB; Hu DF
    IUBMB Life; 2019 Dec; 71(12):1857-1875. PubMed ID: 31381269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion.
    Edwards LA; Woolard K; Son MJ; Li A; Lee J; Ene C; Mantey SA; Maric D; Song H; Belova G; Jensen RT; Zhang W; Fine HA
    J Natl Cancer Inst; 2011 Aug; 103(15):1162-78. PubMed ID: 21771732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue growth factor (CTGF/CCN2) is negatively regulated during neuron-glioblastoma interaction.
    Romão LF; Mendes FA; Feitosa NM; Faria JC; Coelho-Aguiar JM; de Souza JM; Moura Neto V; Abreu JG
    PLoS One; 2013; 8(1):e55605. PubMed ID: 23383241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krüppel-like factor 8 (KLF8) is expressed in gliomas of different WHO grades and is essential for tumor cell proliferation.
    Schnell O; Romagna A; Jaehnert I; Albrecht V; Eigenbrod S; Juerchott K; Kretzschmar H; Tonn JC; Schichor C
    PLoS One; 2012; 7(1):e30429. PubMed ID: 22276196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.
    Guo RM; Zhao CB; Li P; Zhang L; Zang SH; Yang B
    ASN Neuro; 2018; 10():1759091418781949. PubMed ID: 29914265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMP3 as a prognostic biomarker correlates with EMT in GBM.
    Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
    BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.
    Gao YB; Xiang ZL; Zhou LY; Wu ZF; Fan J; Zeng HY; Zeng ZC
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):669-79. PubMed ID: 23307318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
    Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J
    Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients.
    Bai YH; Zhan YB; Yu B; Wang WW; Wang L; Zhou JQ; Chen RK; Zhang FJ; Zhao XW; Duan WC; Wang YM; Liu J; Bao JJ; Zhang ZY; Liu XZ
    Cell Physiol Biochem; 2018; 48(4):1755-1770. PubMed ID: 30078018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDCL3 as a prognostic factor and associated with the VEGF signaling pathway in glioma.
    Yang B; Zheng G; Lu F
    J Gene Med; 2024 Aug; 26(8):e3724. PubMed ID: 39107869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma.
    Zhong WJ; Zhang LZ; Yue F; Yuan L; Zhang Q; Li X; Lin L
    Cancer Biomark; 2024; 40(3-4):297-317. PubMed ID: 39213054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
    Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme.
    Yin D; Chen W; O'Kelly J; Lu D; Ham M; Doan NB; Xie D; Wang C; Vadgama J; Said JW; Black KL; Koeffler HP
    Int J Cancer; 2010 Nov; 127(10):2257-67. PubMed ID: 20162579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CCT8 and its significance for tumor cell proliferation, migration and invasion in glioma.
    Qiu X; He X; Huang Q; Liu X; Sun G; Guo J; Yuan D; Yang L; Ban N; Fan S; Tao T; Wang D
    Pathol Res Pract; 2015 Oct; 211(10):717-25. PubMed ID: 26304164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.